Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Publication Date Organization
Feb
18
2016
 California Provision Goes Slack re: Food Law Keller and Heckman LLP
Feb
18
2016
 Sandoz Asks Supreme Court To Reverse Biosimilar Decision Foley & Lardner LLP
Feb
17
2016
 FDA Aims to Expand Sentinel Capabilities, Include Evaluation of Drug Effectiveness McDermott Will & Schulte LLP
Feb
17
2016
 60-Day Rule Is Final: Assessing Your Organization’s Safeguards Morgan, Lewis & Bockius LLP
Feb
17
2016
 CMS Relaxes 60-day Overpayment “Look Back” Period for Medicare Providers Barnes & Thornburg LLP
Feb
17
2016
 FCA Claims Based on Average Wholesale Price Theory Barred by Public Disclosure Bar McDermott Will & Schulte LLP
Feb
17
2016
 Cannabis-Related Contract Enforcement: Solution Presents Itself? Wilson Elser Moskowitz Edelman & Dicker LLP
Feb
17
2016
 Menu Labeling in the House: FDA Requirements Keller and Heckman LLP
Feb
16
2016
 CMS Notifies States of AMP Rule Requirements: 340B Providers Should Take Note Mintz
Feb
16
2016
 Gluten-Free Go-Round re: Food Labeling Keller and Heckman LLP
Feb
13
2016
 USDA Announces New Standards to Reduce Salmonella and Campylobacter in Poultry Morgan, Lewis & Bockius LLP
Feb
13
2016
 CMA Fines GlaxoSmithKline and Several Generic Companies £45 million for Delaying Market Entry of Generic Paroxetine in the UK Covington & Burling LLP
Feb
12
2016
 FDA Issues Draft Guidance for Connected Medical Devices Jackson Lewis P.C.
Feb
12
2016
 TTB Issues Ruling on Category Management under Federal Tied-House Statute McDermott Will & Schulte LLP
Feb
12
2016
 Cannabidiol: (Clinical) Trials and Tribulations Keller and Heckman LLP
Feb
12
2016
 What the Administration Actually Can Do on Drug Pricing Mintz
Feb
11
2016
 FDA Panel Shows Strong Support for Remicade Biosimilar Foley & Lardner LLP
Feb
11
2016
 Recent Revisions to Internal Revenue Code Affecting Alcohol Beverages McDermott Will & Schulte LLP
Feb
11
2016
 Soda Shakedown re: Sugar Tax Keller and Heckman LLP
Feb
11
2016
 Remicade Biosimilar Closer To Approval, But Patent Dance Goes On Foley & Lardner LLP
Feb
10
2016
 Positive FDA Advisory Committee Vote for First Monoclonal Antibody Biosimilar – But Will Patent Dispute Delay Launch? Mintz
Feb
10
2016
 Drug Shortages are Forcing Treatments to be Rationed Stark & Stark
Feb
10
2016
 FDA Unveils Action Plan to Combat Opioid Abuse
Feb
10
2016
 First Monoclonal Antibody Biosimilar in U.S. Gets One Step Closer to FDA Approval Mintz
Feb
10
2016
 PTAB Institutes Trial On Previously Challenged Cabilly Patent
Feb
10
2016
 Deciphering Final AMP Rule – Key Provisions Impacting Pharmacies, PBMs, and Manufacturers Mintz
Feb
10
2016
 FDA Food Funding for FY 2017 Keller and Heckman LLP
Feb
10
2016
 USDA Declares “Do-Over” on Overhaul of Biotechnology Regulations Beveridge & Diamond PC
Displaying 10165 - 10192 of 12611
Subscribe to The 10 Latest Biological, Life Sciences, and Cleantech Law Articles
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters.

 

Sign Up for any (or all) of our 25+ Newsletters